(4/4) We hope to see you there! #healthpolicy #healthequity #DCEA #HTA #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @zanfinaa.bsky.social @sallysansom.bsky.social

(3/4) @hadleyssmith.bsky.social (@harvardmed.bsky.social‬) will share a framework for equity in genomics, highlighting data equity, evidence standards & how #DCEA can guide fairer decisions in precision health

(2/4) Melanie Lloyd (@monashuniversity.bsky.social‬) will explore how #DCEA differs from traditional CEA, showing through a gestational diabetes case study how implementation choices shape the balance between equity & efficiency in healthcare

(4/4) We hope to see you there! #mendelianrandomisation #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @sallysansom.bsky.social

(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models.‬ Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.

(2/4) @zanfinaa.bsky.social (Monash University) will discuss how health economic models help set healthcare priorities & evaluate intervention value - especially given the limits of RCTs. Using CVD prevention as a case study, she’ll show how Mendelian randomization can improve RWE in CEA.

(4/4) We hope to see you there! #healthpolicy #healthequity #DCEA #HTA #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @zanfinaa.bsky.social sky.social @sallysansom.bsky.social

(3/4) Dr @hadleyssmith.bsky.social (@harvardmed.bsky.social) will share a framework for equity in genomics, highlighting data equity, evidence standards & how #DCEA can guide fairer decisions in precision health

(2/4) Dr Melanie Lloyd (@monashuniversity.bsky.social) will explore how DCEA differs from traditional CEA, showing through a gestational diabetes case study how implementation choices shape the balance between equity & efficiency in healthcare

(4/4) We hope to see you there! #mendelianrandomisation #IHEA #healtheconomics #genomics #precisionmedicine

@jbuchanan-ox.bsky.social @iliasgoranitis.bsky.social @sallysansom.bsky.social

(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models.‬ Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.

(2/4) @zanfinaa.bsky.social (Monash University) will discuss how health economic models help set healthcare priorities & evaluate intervention value - especially given the limits of RCTs. Using CVD prevention as a case study, she’ll show how Mendelian randomization can improve RWE in CEA.

(4/4) We hope to see you there! #mendelianrandomisation #IHEA #healtheconomics #genomics #precisionmedicine

(3/4) @padraigdixon.bsky.social (University of Oxford) will present a novel approach to estimate long-term cost-effectiveness of health interventions without RCTs/Markov models.‬ Using a prostate cancer prevention case study, he’ll show how MR can link genetic liability to healthcare costs & QALYs.

(2/4) @zanfinaa.bsky.social (Monash University) will discuss how health economic models help set healthcare priorities & evaluate intervention value - especially given the limits of RCTs.
Using CVD prevention as a case study, she’ll show how Mendelian randomization can improve RWE in CEA.